Takeda Pharmaceutical Co. Ltd., 10% Owner at Phathom Pharmaceuticals, Inc. (PHAT), sold 40,232 shares at $36.20 ($1.4M) on 2021-06-01, disclosed to the SEC on 2021-06-02.
Open-market sale of $1.4M PHAT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.37 | 4,133 | $146K | 10.1% |
| 2 | $35.37 | 4,133 | $146K | 10.1% |
| 3 | $36.40 | 2,668 | $97K | 6.7% |
| 4 | $36.40 | 2,668 | $97K | 6.7% |
| 5 | $37.55 | 2,104 | $79K | 5.5% |
| 6 | $37.55 | 2,104 |
| $79K |
| 5.5% |
| 7 | $35.55 | 7,244 | $258K | 17.8% |
| 8 | $35.55 | 7,244 | $258K | 17.8% |
| 9 | $36.20 | 3,967 | $144K | 9.9% |
| 10 | $36.20 | 3,967 | $144K | 9.9% |
| Total | $35.96 avg | 40,232 | $1.4M | 100% |
| Filing → |
| DAWN | SELL | 2021-12-09 | $9.9M | — | Filing → |
| PHAT | SELL | 2021-11-08 | $20.9M | — | Filing → |
| PHAT | SELL | 2021-07-09 | $183K | — | Filing → |